Helicobacter pylori Modulates Cisplatin Sensitivity in Gastric Cancer by Down-Regulating miR-141 Expression

Helicobacter

Volumn 19, Issue 3, 2014, Pages 174-181

  Zhou, Xiaoying ^a,b   Su, Jing ^a,b   Zhu, Li ^a,c   Zhang, Guoxin ^a,b  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c People's Hospital of Jingjiang   (China)

Author keywords

Cisplatin sensitivity; Gastric cancer; Helicobacter pylori; MiR 141

Indexed keywords

CISPLATIN; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MICRORNA 141; ANTINEOPLASTIC AGENT; KEAP1 PROTEIN, HUMAN; MICRORNA; MIRN141 MICRORNA, HUMAN; SIGNAL PEPTIDE;

APOPTOSIS; ARTICLE; CELL VIABILITY; DOWN REGULATION; DRUG SENSITIVITY; FLOW CYTOMETRY; GENE EXPRESSION; HELICOBACTER INFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; UPREGULATION; WESTERN BLOTTING; ADULT; BIOSYNTHESIS; CELL SURVIVAL; DRUG EFFECTS; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; MALE; MIDDLE AGED; PHYSIOLOGY; STOMACH NEOPLASMS; TREATMENT OUTCOME;

HELICOBACTER PYLORI;

ADULT; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL SURVIVAL; CISPLATIN; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 84899492242     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/hel.12120     Document Type: Article

References (26)

1. Venerito M, Selgrad M, Malfertheiner P. Helicobacter pylori: gastric cancer and extragastric malignancies - clinical aspects. Helicobacter 2013;18:39-43.
2. Kang G, Hwang WC, Do IG, et al. Exome sequencing identifies early gastric carcinoma as an early stage of advanced gastric cancer. PLoS One 2013;8:e82770.
3. Yamamoto K, Kato M, Takahashi M, et al. Clinicopathological analysis of early-stage gastric cancers detected after successful eradication of Helicobacter pylori. Helicobacter 2011;16:210-6.
4. O'Connor A, Molina-Infante J, Gisbert JP, O'Morain C. Treatment of Helicobacter pylori infection 2013. Helicobacter 2013;18:58-65.
5. Sheh A, Lee CW, Masumura K, Rickman BH, Nohmi T, Wogan GN, Fox JG, Schauer DB. Mutagenic potency of Helicobacter pylori in the gastric mucosa of mice is determined by sex and duration of infection. Proc Natl Acad Sci USA 2010;107:15217-22.
6. Wang XQ, Yan H, Terry PD, Wang JS, Cheng L, Wu WA, Hu SK. Interaction between dietary factors and Helicobacter pylori infection in noncardia gastric cancer: a population-based case-control study in China. J Am Coll Nutr 2012;31:375-84.
7. Kim SG, Song HJ, Choi IJ, et al. Korean College of Helicobacter, Upper Gastrointestinal Research. Helicobacter pylori eradication on iatrogenic ulcer by endoscopic resection of gastric tumour: a prospective, randomized, placebo-controlled multi-centre trial. Dig Liver Dis 2013;45:385-9.
8. Wang F, Sun GP, Zou YF, Zhong F, Ma T, Li XQ, Wu D. Helicobacter pylori infection predicts favorable outcome in patients with gastric cancer. Curr Oncol 2013;20:e388-95.
9. Choi IK, Sung HJ, Lee JH, Kim JS, Seo JH. The relationship between Helicobacter pylori infection and the effects of chemotherapy in patients with advanced or metastatic gastric cancer. Cancer Chemother Pharmacol 2012;70:555-8.
10. Wang F, Sun G, Zou Y, Zhong F, Ma T, Li X. Protective role of Helicobacter pylori infection in prognosis of gastric cancer: evidence from 2, 454 patients with gastric cancer. PLoS One 2013;8:e62440.
11. Li H, Xu H, Shen H, Li H. microRNA-106a modulates cisplatin sensitivity by targeting PDCD4 in human ovarian cancer cells. Oncol Lett 2014;7:183-8.
12. Yang N, Kaur S, Volinia S, et al. MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res 2008;68:10307-14.
13. van Jaarsveld MT, Helleman J, Boersma AW, et al. miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells. Oncogene 2013;32:4284-93.
14. Liou JM, Lin JT, Chang CY, Chen MJ, Cheng TY, Lee YC, Chen CC, Sheng WH, Wang HP, Wu MS. Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design. Gut 2010;59:572-8.
15. Luo YH, Yan J, Mao YF. Helicobacter pylori lipopolysaccharide: biological activities in vitro and in vivo, pathological correlation to human chronic gastritis and peptic ulcer. World J Gastroenterol 2004;10:2055-9.
16. Choi CW, Kim HW, Shin DH, Kang DH, Hong YM, Park JH, Park SB, Cho M, Lee JH. The risk factors for discrepancy after endoscopic submucosal dissection of gastric category 3 lesion (low grade dysplasia). Dig Dis Sci 2014;59:421-7.
17. Li J, Qin S, Xu J, et al. Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trial. J Clin Oncol 2013;31:3219-25.
18. Cao W, Yang W, Fan R, Li H, Jiang J, Geng M, Jin Y, Wu Y. miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/surviving pathway. Tumour Biol 2014;35:1287-95.
19. Yamagishi T, Sahni S, Sharp DM, Arvind A, Jansson PJ, Richardson DR. P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration. J Biol Chem 2013;288:31761-71.
20. Yan LH, Wang XT, Yang J, Kong FB, Lian C, Wei WY, Luo W, Xie YB, Xiao Q. Reversal of multidrug resistance in gastric cancer cells by E2F-1 downregulation in vitro and in vivo. J Cell Biochem 2014;115:34-41.
21. Matsushima K, Isomoto H, Inoue N, Nakayama T, Hayashi T, Nakayama M, Nakao K, Hirayama T, Kohno S. MicroRNA signatures in Helicobacter pylori-infected gastric mucosa. Int J Cancer 2011;128:361-70.
22. Díaz-Martín J, Díaz-López A, Moreno-Bueno G, Castilla MÁ, Rosa-Rosa JM, Cano A, Palacios J. A core microRNA signature associated with inducers of the epithelial-to-mesenchymal transition. J Pathol 2014;232:319-29.
23. Xu L, Li Q, Xu D, Wang Q, An Y, Du Q, Zhang J, Zhu Y, Miao Y. hsa-miR-141 downregulates TM4SF1 to inhibit pancreatic cancer cell invasion and migration. Int J Oncol 2014;44:459-66.
24. Al-Mulla F, Bitar MS, Feng J, Park S, Yeung KC. A new model for raf kinase inhibitory protein induced chemotherapeutic resistance. PLoS One 2012;7:e29532.
25. Jaramillo MC, Zhang DD. The emerging role of the Nrf2-Keap1 signaling pathway in cancer. Genes Dev 2013;27:2179-91.
26. Imanaka Y, Tsuchiya S, Sato F, Shimada Y, Shimizu K, Tsujimoto G. MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma. J Hum Genet 2011;56:270-6.